Matosin N - Search Results

1

Common variation in ZNF804A (rs1344706) is not associated with brain morphometry in schizophrenia or healthy participants.

Quidé Y, Matosin N, Atkins JR, Fitzsimmons C, Cairns MJ, Carr VJ; Australian Schizophrenia Research Bank (ASRB); Green MJ. Quidé Y, et al. Among authors: matosin n. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:12-20. doi: 10.1016/j.pnpbp.2017.12.007. Epub 2017 Dec 13. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 29247760

2

Possibility of a sex-specific role for a genetic variant in FRMPD4 in schizophrenia, but not cognitive function.

Matosin N, Green MJ, Andrews JL, Newell KA, Fernandez-Enright F. Matosin N, et al. Neuroreport. 2016 Jan 6;27(1):33-8. doi: 10.1097/WNR.0000000000000491. Neuroreport. 2016. PMID: 26555035

3

Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia.

Matosin N, Newell KA, Quidé Y, Andrews JL, Teroganova N, Green MJ, Fernandez F. Matosin N, et al. Brain Imaging Behav. 2018 Apr;12(2):509-517. doi: 10.1007/s11682-017-9712-0. Brain Imaging Behav. 2018. PMID: 28405888

4

Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats.

Andrews JL, Newell KA, Matosin N, Huang XF, Fernandez-Enright F. Andrews JL, et al. Among authors: matosin n. Prog Neuropsychopharmacol Biol Psychiatry. 2015 Dec 3;63:91-7. doi: 10.1016/j.pnpbp.2015.06.003. Epub 2015 Jun 10. Prog Neuropsychopharmacol Biol Psychiatry. 2015. PMID: 26071990

5

Metabotropic Glutamate Receptor 5 as a Point of Convergence for Models of Obsessive-Compulsive Disorder and Autism Spectrum Disorder.

Matosin N, Siegel SJ. Matosin N, et al. Biol Psychiatry. 2016 Oct 1;80(7):504-6. doi: 10.1016/j.biopsych.2016.08.005. Biol Psychiatry. 2016. PMID: 27601339 No abstract available.

6

Understanding the Molecular Mechanisms Underpinning Gene by Environment Interactions in Psychiatric Disorders: The FKBP5 Model.

Matosin N, Halldorsdottir T, Binder EB. Matosin N, et al. Biol Psychiatry. 2018 May 15;83(10):821-830. doi: 10.1016/j.biopsych.2018.01.021. Epub 2018 Mar 21. Biol Psychiatry. 2018. PMID: 29573791 Review.

7

Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics.

Newell KA, Matosin N. Newell KA, et al. Among authors: matosin n. BMC Psychiatry. 2014 Jan 28;14:23. doi: 10.1186/1471-244X-14-23. BMC Psychiatry. 2014. PMID: 24472577 Free PMC article.

8

mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.

Engel M, Snikeris P, Matosin N, Newell KA, Huang XF, Frank E. Engel M, et al. Among authors: matosin n. Psychopharmacology (Berl). 2016 Apr;233(8):1349-59. doi: 10.1007/s00213-016-4230-0. Epub 2016 Feb 10. Psychopharmacology (Berl). 2016. PMID: 26861891

9

Erratum to: mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.

Engel M, Snikeris P, Matosin N, Newell KA, Huang XF, Frank E. Engel M, et al. Among authors: matosin n. Psychopharmacology (Berl). 2016 Apr;233(8):1537. doi: 10.1007/s00213-016-4261-6. Psychopharmacology (Berl). 2016. PMID: 26955838 No abstract available.

10

Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia.

Matosin N, Newell KA. Matosin N, et al. Neurosci Biobehav Rev. 2013 Mar;37(3):256-68. doi: 10.1016/j.neubiorev.2012.12.005. Epub 2012 Dec 17. Neurosci Biobehav Rev. 2013. PMID: 23253944 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters